Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 285


Anakinra in children and adults with Still's disease.

Vastert SJ, Jamilloux Y, Quartier P, Ohlman S, Osterling Koskinen L, Kullenberg T, Franck-Larsson K, Fautrel B, de Benedetti F.

Rheumatology (Oxford). 2019 Nov 1;58(Supplement_6):vi9-vi22. doi: 10.1093/rheumatology/kez350.


Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.

Lukas C, Mary J, Debandt M, Daïen C, Morel J, Cantagrel A, Fautrel B, Combe B.

Arthritis Res Ther. 2019 Nov 15;21(1):243. doi: 10.1186/s13075-019-2020-x.


An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databases.

Vanier A, Smolen JS, Allaart CF, Vollenhoven RV, Verschueren P, Vastesaeger N, Saevarsdottir S, Visser K, Aletaha D, Combe B, Fautrel B.

Rheumatology (Oxford). 2019 Nov 13. pii: kez542. doi: 10.1093/rheumatology/kez542. [Epub ahead of print]


Predictive factors of tumour necrosis inhibitor treatment persistence for rheumatoid arthritis: An observational study in 8052 patients.

Fautrel B, Belhassen M, Hudry C, Woronoff-Lemsi MC, Levy-Bachelot L, Van Ganse E, Tubach F.

Joint Bone Spine. 2019 Oct 24. pii: S1297-319X(19)30151-4. doi: 10.1016/j.jbspin.2019.10.004. [Epub ahead of print]


A simplified radiographic score effectively predicts radiographic progression of early arthritis in a large nationwide French cohort.

Carvajal Alegria G, Milin M, Gandjbakhch F, Saraux A, Bailly F, Jousse-Joulin S, Schaeverbeke T, Lukas C, Foltz V, Fautrel B, Devauchelle-Pensec V.

Rheumatology (Oxford). 2019 Oct 19. pii: kez450. doi: 10.1093/rheumatology/kez450. [Epub ahead of print]


Reply to the Letter: 'Thrombotic microangiopathy in adult-onset Still's disease: the story is just beginning'.

Mitrovic S, Hertig A, Fautrel B.

Expert Rev Clin Immunol. 2019 Nov;15(11):1125-1126. doi: 10.1080/1744666X.2019.1682893. Epub 2019 Oct 31. No abstract available.


Predictive factors of tumour necrosis inhibitor treatment persistence for rheumatoid arthritis: An observational study in 8052 patients.

Fautrel B, Belhassen M, Hudry C, Woronoff-Lemsi MC, Levy-Bachelot L, Van Ganse E, Tubach F.

Joint Bone Spine. 2019 Oct 11. pii: S1297-319X(19)30148-4. doi: 10.1016/j.jbspin.2019.09.017. [Epub ahead of print] No abstract available.


Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire.

Myasoedova E, De Thurah A, Erpelding ML, Schneeberger EE, Maribo T, Citera G, Davis JM, Matteson EL, Crowson CS, Fautrel B, Guillemin F.

Semin Arthritis Rheum. 2019 Sep 11. pii: S0049-0172(19)30330-0. doi: 10.1016/j.semarthrit.2019.09.004. [Epub ahead of print]


The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA).

Barroso N, Woodworth TG, Furst DE, Guillemin F, Fautrel BJ, Borazan N, Kafaja S, Brook J, Elashoff DA, Ranganath VK.

Clin Rheumatol. 2020 Jan;39(1):189-199. doi: 10.1007/s10067-019-04755-3. Epub 2019 Sep 6.


Effect of Baricitinib and Adalimumab in Reducing Pain and Improving Function in Patients with Rheumatoid Arthritis in Low Disease Activity: Exploratory Analyses from RA-BEAM.

Fautrel B, Kirkham B, Pope JE, Takeuchi T, Gaich C, Quebe A, Zhu B, de la Torre I, De Leonardis F, Taylor PC.

J Clin Med. 2019 Sep 5;8(9). pii: E1394. doi: 10.3390/jcm8091394.


AA amyloidosis secondary to adult onset Still's disease: About 19 cases.

Delplanque M, Pouchot J, Ducharme-Bénard S, Fautrel BJ, Benyamine A, Daniel L, Gendre T, Grateau G, Georgin-Lavialle S.

Semin Arthritis Rheum. 2020 Feb;50(1):156-165. doi: 10.1016/j.semarthrit.2019.08.005. Epub 2019 Aug 10. Review.


Criteria for inclusion in programs of functional restoration for chronic low back pain: Pragmatic Study.

Assadourian M, Bailly F, Letellier P, Potel A, Duplan B, Beaudreuil J, Dupeyron A, Foltz V, Ibrahim-Nasser N, Griffoul I, Ascione S, Morardet L, Le Ralle M, Fautrel B, Gossec L.

Ann Phys Rehabil Med. 2019 Aug 14. pii: S1877-0657(19)30112-5. doi: 10.1016/ [Epub ahead of print]


Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations.

Kedra J, Radstake T, Pandit A, Baraliakos X, Berenbaum F, Finckh A, Fautrel B, Stamm TA, Gomez-Cabrero D, Pristipino C, Choquet R, Servy H, Stones S, Burmester G, Gossec L.

RMD Open. 2019 Jul 18;5(2):e001004. doi: 10.1136/rmdopen-2019-001004. eCollection 2019.


Impact of comorbidities and functional impairment on 5-year loss of health utility in patients with lower-limb osteoarthritis in the KHOALA cohort.

Omorou AY, Achit H, Wieczorek M, Pouchot J, Fautrel B, Rat AC, Guillemin F.

Qual Life Res. 2019 Nov;28(11):3047-3054. doi: 10.1007/s11136-019-02243-4. Epub 2019 Jul 4.


[It is time to reconcile systemic juvenile idiopathic arthritis and adult-onset Still's disease].

Jamilloux Y, Georgin-Lavialle S, Sève P, Belot A, Fautrel B.

Rev Med Interne. 2019 Oct;40(10):635-636. doi: 10.1016/j.revmed.2019.06.001. Epub 2019 Jun 17. French. No abstract available.


Cost-effectiveness of five different anti-tumour necrosis factor tapering strategies in rheumatoid arthritis: a modelling study.

Verhoef LM, Bos D, van den Ende C, van den Hoogen F, Fautrel B, Hulscher ME, Kievit W, den Broeder AA.

Scand J Rheumatol. 2019 Nov;48(6):439-447. doi: 10.1080/03009742.2019.1613674. Epub 2019 Jun 21.


Knowledge of and expectations about functional restoration programs for chronic low back pain: A mirror survey of 150 patients and 80 physicians in 2017.

Letellier P, Bailly F, Assadourian M, Potel A, Foltz V, Ascione S, Morardet L, Le Ralle M, Fautrel B, Dupeyron A, Ibrahim-Nasser N, Griffoul-Espitalier I, Duplan B, Beaudreuil J, Gossec L.

Joint Bone Spine. 2019 Nov;86(6):812-813. doi: 10.1016/j.jbspin.2019.06.002. Epub 2019 Jun 16. No abstract available.


Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial.

Taylor PC, Lee YC, Fleischmann R, Takeuchi T, Perkins EL, Fautrel B, Zhu B, Quebe AK, Gaich CL, Zhang X, Dickson CL, Schlichting DE, Patel H, Durand F, Emery P.

J Clin Med. 2019 Jun 12;8(6). pii: E831. doi: 10.3390/jcm8060831.


Alcohol is not the missing link between Porphyromonas gingivalis-related periodontitis and radiological progression in early rheumatoid arthritis: comment on 'Porphyromonas gingivalis experimentally induces periodontitis and an anti-CCP2-associated arthritis in the rat'.

Hillion J, Bellier A, Romand X, Fautrel B, Mariette X, Sagéloli F, Baillet A, Gaudin P.

Ann Rheum Dis. 2019 Jun 14. pii: annrheumdis-2019-215603. doi: 10.1136/annrheumdis-2019-215603. [Epub ahead of print] No abstract available.


Developing a Preliminary Definition and Domains of Flare in Knee and Hip Osteoarthritis (OA): Consensus Building of the Flare-in-OA OMERACT Group.

Guillemin F, Ricatte C, Barcenilla-Wong A, Schoumacker A, Cross M, Alleyrat C, Buttel T, Cembalo M, Manseur H, Urban H, Fautrel B, Conaghan PG, Hawker G, Rutherford C, March L, Spitz E, Hunter DJ.

J Rheumatol. 2019 Sep;46(9):1188-1191. doi: 10.3899/jrheum.181085. Epub 2019 May 15.


Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from STRASS study.

Marotte H, Rinaudo-Gaujous M, Petiet C, Fautrel B, Paul S.

Ann Rheum Dis. 2019 May 2. pii: annrheumdis-2019-215546. doi: 10.1136/annrheumdis-2019-215546. [Epub ahead of print] No abstract available.


Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis.

Tanaka Y, Fautrel B, Keystone EC, Ortmann RA, Xie L, Zhu B, Issa M, Patel H, Gaich CL, de Bono S, Rooney TP, Taylor PC.

Ann Rheum Dis. 2019 Jul;78(7):890-898. doi: 10.1136/annrheumdis-2018-214529. Epub 2019 Apr 30.


Health resource use and costs of symptomatic knee and/or hip osteoarthritis.

Salmon JH, Rat AC, Achit H, Ngueyon-Sime W, Gard C, Guillemin F, Jolly D, Fautrel B.

Osteoarthritis Cartilage. 2019 Jul;27(7):1011-1017. doi: 10.1016/j.joca.2019.03.005. Epub 2019 Mar 25.


Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain.

Puyraimond-Zemmour D, Granger B, Molto A, Gaujoux-Viala C, Guillemin F, Ruyssen-Witrand A, Dougados M, Fautrel B, Gossec L.

Arthritis Res Ther. 2019 Feb 19;21(1):63. doi: 10.1186/s13075-019-1841-y.


Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy.

Vercruysse F, Barnetche T, Lazaro E, Shipley E, Lifermann F, Balageas A, Delbrel X, Fautrel B, Richez C, Schaeverbeke T, Truchetet ME.

Arthritis Res Ther. 2019 Feb 12;21(1):53. doi: 10.1186/s13075-019-1838-6.


Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis.

Choy E, Caporali R, Xavier R, Fautrel B, Sanmarti R, Bao M, Devenport J, Pethö-Schramm A.

Rheumatology (Oxford). 2019 Jun 1;58(6):1056-1064. doi: 10.1093/rheumatology/key393.


Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.

Rosenzwajg M, Lorenzon R, Cacoub P, Pham HP, Pitoiset F, El Soufi K, RIbet C, Bernard C, Aractingi S, Banneville B, Beaugerie L, Berenbaum F, Champey J, Chazouilleres O, Corpechot C, Fautrel B, Mekinian A, Regnier E, Saadoun D, Salem JE, Sellam J, Seksik P, Daguenel-Nguyen A, Doppler V, Mariau J, Vicaut E, Klatzmann D.

Ann Rheum Dis. 2019 Feb;78(2):209-217. doi: 10.1136/annrheumdis-2018-214229. Epub 2018 Nov 24.


Hormonal Risk Factors for Osteoporosis: Different Profile Among Antipsychotics.

Raffin M, Bonnot O, Giannitelli M, Xavier J, Bodeau N, Bibrac B, Leban M, Fautrel B, Menard ML, Consoli A, Cohen D.

J Child Adolesc Psychopharmacol. 2018 Nov 13. doi: 10.1089/cap.2017.0158. [Epub ahead of print]


Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis.

Quistrebert J, Hässler S, Bachelet D, Mbogning C, Musters A, Tak PP, Wijbrandts CA, Herenius M, Bergstra SA, Akdemir G, Johannesson M, Combe B, Fautrel B, Chollet-Martin S, Gleizes A, Donnellan N, Deisenhammer F, Davidson J, Hincelin-Mery A, Dönnes P, Fogdell-Hahn A, De Vries N, Huizinga T, Abugessaisa I, Saevarsdottir S, Hacein-Bey-Abina S, Pallardy M, Broët P, Mariette X; ABIRISK Consortium.

Semin Arthritis Rheum. 2019 Jun;48(6):967-975. doi: 10.1016/j.semarthrit.2018.10.006. Epub 2018 Oct 12.


Update of French society for rheumatology recommendations for managing rheumatoid arthritis.

Daien C, Hua C, Gaujoux-Viala C, Cantagrel A, Dubremetz M, Dougados M, Fautrel B, Mariette X, Nayral N, Richez C, Saraux A, Thibaud G, Wendling D, Gossec L, Combe B.

Joint Bone Spine. 2019 Mar;86(2):135-150. doi: 10.1016/j.jbspin.2018.10.002. Epub 2018 Oct 10.


Detection of Flares by Decrease in Physical Activity, Collected Using Wearable Activity Trackers in Rheumatoid Arthritis or Axial Spondyloarthritis: An Application of Machine Learning Analyses in Rheumatology.

Gossec L, Guyard F, Leroy D, Lafargue T, Seiler M, Jacquemin C, Molto A, Sellam J, Foltz V, Gandjbakhch F, Hudry C, Mitrovic S, Fautrel B, Servy H.

Arthritis Care Res (Hoboken). 2019 Oct;71(10):1336-1343. doi: 10.1002/acr.23768.


Use of Wearable Activity Trackers to Improve Physical Activity Behavior in Patients With Rheumatic and Musculoskeletal Diseases: A Systematic Review and Meta-Analysis.

Davergne T, Pallot A, Dechartres A, Fautrel B, Gossec L.

Arthritis Care Res (Hoboken). 2019 Jun;71(6):758-767. doi: 10.1002/acr.23752. Epub 2019 Apr 23.


Mechanisms, biomarkers and targets for adult-onset Still's disease.

Feist E, Mitrovic S, Fautrel B.

Nat Rev Rheumatol. 2018 Oct;14(10):603-618. doi: 10.1038/s41584-018-0081-x. Review.


Reply to the comment of Alkan Melikoglu 'Joint manifestations can provide diagnostic clues in Morquio syndrome, a case report'.

Mitrovic S, Gouze H, Schaeverbeke T, Gossec L, Fautrel B.

Joint Bone Spine. 2019 Jan;86(1):123-124. doi: 10.1016/j.jbspin.2018.06.016. Epub 2018 Jul 29. No abstract available.


Cost Effectiveness of Intra-Articular Hyaluronic Acid and Disease-Modifying Drugs in Knee Osteoarthritis.

Salmon JH, Rat AC, Charlot-Lambrecht I, Eschard JP, Jolly D, Fautrel B.

Pharmacoeconomics. 2018 Nov;36(11):1321-1331. doi: 10.1007/s40273-018-0695-5.


Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis.

Hilliquin S, Hugues B, Mitrovic S, Gossec L, Fautrel B.

Ann Rheum Dis. 2018 Aug;77(8):1099-1106. doi: 10.1136/annrheumdis-2017-212612. Epub 2018 Jun 8.


Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort.

Louveau B, De Rycke Y, Lafourcade A, Saraux A, Guillemin F, Tubach F, Fautrel B, Hajage D.

Rheumatology (Oxford). 2018 Sep 1;57(9):1563-1573. doi: 10.1093/rheumatology/key122.


Increased severity and epidermal alterations in persistent versus evanescent skin lesions in adult-onset Still disease.

Zuelgaray E, Battistella M, Sallé de Chou C, Vignon-Pennamen MD, Rybojad M, Petit A, Cordoliani F, Chasset F, Bachmeyer C, Fardet L, Fautrel B, Cacoub P, Lipsker D, Bagot M, Bouaziz JD.

J Am Acad Dermatol. 2018 Nov;79(5):969-971. doi: 10.1016/j.jaad.2018.05.020. Epub 2018 May 19. No abstract available.


Moderate alcohol consumption is associated with increased radiological progression in women, but not in men, with early rheumatoid arthritis: results from the ESPOIR cohort (Étude et Suivi des Polyarthrites Indifférenciées Récentes).

Sageloli F, Quesada JL, Fautrel B, Salliot C, Gaudin P, Baillet A.

Scand J Rheumatol. 2018 Nov;47(6):440-446. doi: 10.1080/03009742.2018.1437216. Epub 2018 May 18.


Complications of adult-onset Still's disease and their management.

Mitrovic S, Fautrel B.

Expert Rev Clin Immunol. 2018 May;14(5):351-365. doi: 10.1080/1744666X.2018.1465821. Epub 2018 Apr 26.


Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries.

Choy E, Caporali R, Xavier R, Fautrel B, Sanmarti R, Bao M, Bernasconi C, Pethö-Schramm A.

Rheumatology (Oxford). 2018 Jun 1;57(6):1129. doi: 10.1093/rheumatology/key116. No abstract available.


Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.

Fautrel B, Alten R, Kirkham B, de la Torre I, Durand F, Barry J, Holzkaemper T, Fakhouri W, Taylor PC.

Rheumatol Int. 2018 Jun;38(6):935-947. doi: 10.1007/s00296-018-4005-5. Epub 2018 Mar 21. Review.


Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups.

Feist E, Quartier P, Fautrel B, Schneider R, Sfriso P, Efthimiou P, Cantarini L, Lheritier K, Leon K, Karyekar CS, Speziale A.

Clin Exp Rheumatol. 2018 Jul-Aug;36(4):668-675. Epub 2018 Mar 2.


Diabetes at the time of rheumatoid arthritis diagnosis is an independent predictor of pejorative outcomes: Data from the early arthritis ESPOIR cohort.

Daïen CI, Sellam J, Rincheval N, Fautrel B, Saraux A, Morel J, Berenbaum F, Daurès JP, Combe B.

Joint Bone Spine. 2018 Dec;85(6):773-775. doi: 10.1016/j.jbspin.2018.02.004. Epub 2018 Feb 23. No abstract available.


Cost-effectiveness analysis of strategies using new immunological diagnostic tests of latent tuberculosis infection before TNF-blockers therapy.

Freund R, Granger B, Francois C, Carcelain G, Ravaud P, Mariette X, Fautrel B.

Presse Med. 2018 Feb;47(2):e9-e13. doi: 10.1016/j.lpm.2017.09.029. Epub 2018 Feb 23.


Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease.

Gabay C, Fautrel B, Rech J, Spertini F, Feist E, Kötter I, Hachulla E, Morel J, Schaeverbeke T, Hamidou MA, Martin T, Hellmich B, Lamprecht P, Schulze-Koops H, Courvoisier DS, Sleight A, Schiffrin EJ.

Ann Rheum Dis. 2018 Jun;77(6):840-847. doi: 10.1136/annrheumdis-2017-212608. Epub 2018 Feb 22.


Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients.

Gossec L, Kirwan JR, de Wit M, Balanescu A, Gaujoux-Viala C, Guillemin F, Rat AC, Saraux A, Fautrel B, Kvien TK, Dougados M; RAID investigators.

Clin Rheumatol. 2018 Jun;37(6):1503-1510. doi: 10.1007/s10067-018-3998-1. Epub 2018 Feb 21.


Effect of biologics on fatigue in psoriatic arthritis: A systematic literature review with meta-analysis.

Reygaerts T, Mitrovic S, Fautrel B, Gossec L.

Joint Bone Spine. 2018 Jul;85(4):405-410. doi: 10.1016/j.jbspin.2018.01.011. Epub 2018 Feb 13.


Therapeutic strategy for rheumatoid arthritis patients who have achieved remission.

Fautrel B.

Joint Bone Spine. 2018 Dec;85(6):679-685. doi: 10.1016/j.jbspin.2018.02.002. Epub 2018 Feb 13. Review.


Report of two cases of tocilizumab induced recurrent meningitis or meningoencephalitis.

Richebé P, Bailly F, Mariani LL, Pena PS, Pedespan JM, Fautrel B.

Joint Bone Spine. 2018 Oct;85(5):643-644. doi: 10.1016/j.jbspin.2018.01.002. Epub 2018 Jan 31. No abstract available.


Supplemental Content

Loading ...
Support Center